Spontaneous Pneumomediastinum in Patients Diagnosed with COVID-19: A Case Series with Review of Literature
| dc.contributor.author | Chowdhary, Anisa Anila | |
| dc.contributor.author | Nirwan, Lalit | |
| dc.contributor.author | Abi-Ghanem, Alain S. | |
| dc.contributor.author | Arif, Uroosa | |
| dc.contributor.author | Lahori, Simmy | |
| dc.contributor.author | Kassab, Mohamad Bassam | |
| dc.contributor.author | Karout, Samar | |
| dc.contributor.author | Itani, Rania Mazen | |
| dc.contributor.author | Abdalla, Rasha | |
| dc.contributor.author | Naffaa, Lena N. | |
| dc.contributor.author | Karout, Lina | |
| dc.contributor.department | Diagnostic Radiology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:41:11Z | |
| dc.date.available | 2025-01-24T11:41:11Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Background: Spontaneous pneumomediastinum (SPM) is a rare condition defined by the presence of air in the mediastinum in the absence of traumatic or iatrogenic injury. Although the imaging findings and complications of SARS-CoV-2 infection have been reported many times, there are few reports of the prevalence and outcomes of patients with SPM. Purpose: In this paper, we aimed to illustrate the different manifestations, management, and outcome of three cases of SPM in COVID-19 patients and provide an extensive review available literature. Materials and Methods: Detailed report of patients' demographics, clinical presentation, management, and outcome of three cases of COVID-19 induced SPM seen in our institution was provided. Additionally, literature search was employed through March 2021 using Pubmed and Google scholar databases where a total of 22 articles consisting of 35 patients were included. Results: Statistical analysis of the reviewed articles showed that SPM in COVID-19 occurs in patients with a mean age of 55.6 ± 16.7 years. Furthermore, 80% of the 35 patients are males and almost 60% have comorbidities. Intriguingly, SPM in COVID-19 is associated with a 28.5% mortality rate. These findings are consistent with our case series and are different from previous reports of SPM in non-COVID-19 cases where it most commonly occurs in younger individuals and has a self-limiting course with a good outcome. Conclusion: Therefore, SPM in COVID-19 patients occurs in older patients and is potentially associated with a higher mortality rate. Further studies are necessary to assess its role as a prognostic marker of poor outcome. © 2021 The Association of University Radiologists | |
| dc.identifier.doi | https://doi.org/10.1016/j.acra.2021.07.013 | |
| dc.identifier.eid | 2-s2.0-85112545768 | |
| dc.identifier.pmid | 34391638 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29693 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Inc. | |
| dc.relation.ispartof | Academic Radiology | |
| dc.source | Scopus | |
| dc.subject | Covid-19 | |
| dc.subject | Prognostic factor | |
| dc.subject | Sars-cov-2 | |
| dc.subject | Spontaneous pneumomediastinum | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Mediastinal emphysema | |
| dc.subject | Mediastinum | |
| dc.subject | Middle aged | |
| dc.subject | Tomography, x-ray computed | |
| dc.subject | Budesonide | |
| dc.subject | C reactive protein | |
| dc.subject | Clarithromycin | |
| dc.subject | D dimer | |
| dc.subject | Dexamethasone | |
| dc.subject | Doxycycline | |
| dc.subject | Enoxaparin | |
| dc.subject | Ferritin | |
| dc.subject | Immunoglobulin g antibody | |
| dc.subject | Immunoglobulin m | |
| dc.subject | Ivermectin | |
| dc.subject | Lactate dehydrogenase | |
| dc.subject | Meropenem | |
| dc.subject | Methylprednisolone sodium succinate | |
| dc.subject | Mucomix | |
| dc.subject | Pirfenidone | |
| dc.subject | Remdesivir | |
| dc.subject | Respiratory tract agent | |
| dc.subject | Tazar | |
| dc.subject | Unclassified drug | |
| dc.subject | Zinc | |
| dc.subject | Article | |
| dc.subject | Bilevel positive airway pressure | |
| dc.subject | Cardiomegaly | |
| dc.subject | Case report | |
| dc.subject | Clinical article | |
| dc.subject | Clinical feature | |
| dc.subject | Comorbidity | |
| dc.subject | Computer assisted tomography | |
| dc.subject | Coronavirus disease 2019 | |
| dc.subject | Demography | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Disease duration | |
| dc.subject | Dyspnea | |
| dc.subject | Enzyme linked immunosorbent assay | |
| dc.subject | Ferritin blood level | |
| dc.subject | Fever | |
| dc.subject | Ground glass opacity | |
| dc.subject | Hospital admission | |
| dc.subject | Human | |
| dc.subject | Hypertension | |
| dc.subject | Hyponatremia | |
| dc.subject | Lactate dehydrogenase blood level | |
| dc.subject | Lung auscultation | |
| dc.subject | Mortality rate | |
| dc.subject | Nasopharyngeal swab | |
| dc.subject | Outcome assessment | |
| dc.subject | Pleura effusion | |
| dc.subject | Pneumomediastinum | |
| dc.subject | Productive cough | |
| dc.subject | Systematic review | |
| dc.subject | Thorax radiography | |
| dc.subject | Urea nitrogen blood level | |
| dc.subject | Diagnostic imaging | |
| dc.subject | X-ray computed tomography | |
| dc.title | Spontaneous Pneumomediastinum in Patients Diagnosed with COVID-19: A Case Series with Review of Literature | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1